Puskas John D, Edwards Fred H, Pappas Paul A, O'Brien Sean, Peterson Eric D, Kilgo Patrick, Ferguson T Bruce
Emory University School of Medicine, Atlanta, Georgia 30308, USA.
Ann Thorac Surg. 2007 Nov;84(5):1447-54; discussion 1454-6. doi: 10.1016/j.athoracsur.2007.06.104.
Women have historically had greater morbidity and mortality than men after conventional coronary artery bypass grafting (CABG) on cardiopulmonary bypass (ONCAB). It is controversial whether off-pump CABG (OPCAB) alters this gender-based disparity.
The Society of Thoracic Surgeons National Cardiac Database was reviewed for risk factors and clinical outcomes of 42,477 consecutive, nonemergency, isolated, primary ONCAB or OPCAB cases performed at 63 North American centers that performed more than 100 OPCAB cases between January 1, 2004, and December 31, 2005. Odds ratios for adverse events, adjusted for 32 clinical and demographic covariates, were compared by multiple logistic regression models between women and men who had OPCAB versus ONCAB. All analyses were by intention-to-treat; 355 (2.2%) patients converted from OPCAB to ONCAB intraoperatively were included in the OPCAB group.
Women (n = 11,785) and those treated with OPCAB (n = 16,245) were older and had more comorbidities than men (n = 30,662) and those treated with conventional ONCAB (n = 26,202). Overall, adjusted odds ratios for death and most major complications in both men and women were significantly lower with OPCAB than with ONCAB. Among ONCAB cases only, women had a significantly greater adjusted risk of death, prolonged ventilation, and long length of stay than men. In contrast, among OPCAB cases, women had lower risk of reexploration than men and similar risks for death, myocardial infarction, and prolonged ventilation and hospital stay.
OPCAB is associated with lower adjusted risk of death and major adverse events than ONCAB. OPCAB benefits both men and women and reduces the gender disparity in clinical outcomes after CABG.
在传统的体外循环冠状动脉旁路移植术(ONCAB)后,女性的发病率和死亡率历来高于男性。非体外循环冠状动脉旁路移植术(OPCAB)是否会改变这种基于性别的差异存在争议。
回顾胸外科医师协会国家心脏数据库,分析2004年1月1日至2005年12月31日期间在63个北美中心进行的42477例连续、非急诊、孤立、初次ONCAB或OPCAB病例的危险因素和临床结局,这些中心进行了超过100例OPCAB手术。通过多因素逻辑回归模型比较接受OPCAB与ONCAB的女性和男性之间不良事件的比值比,并对32个临床和人口统计学协变量进行校正。所有分析均采用意向性治疗;术中从OPCAB转为ONCAB的355例(2.2%)患者纳入OPCAB组。
女性(n = 11785)和接受OPCAB治疗的患者(n = 16245)比男性(n = 30662)和接受传统ONCAB治疗的患者(n = 26202)年龄更大,合并症更多。总体而言,OPCAB组男性和女性死亡及大多数主要并发症的校正比值比均显著低于ONCAB组。仅在ONCAB病例中,女性死亡、通气时间延长和住院时间延长的校正风险显著高于男性。相比之下,在OPCAB病例中,女性再次手术的风险低于男性,死亡、心肌梗死、通气时间延长和住院时间的风险与男性相似。
与ONCAB相比,OPCAB的校正死亡风险和主要不良事件风险更低。OPCAB对男性和女性均有益,并减少了冠状动脉旁路移植术后临床结局的性别差异。